denpharm ltd
denpharm ltd Company Information
Company Number
11228555
Next Accounts
Dec 2025
Shareholders
muntazir mehdi hamza ali
arjuman riaz mehdi hamza ali
View AllGroup Structure
View All
Industry
Other personal service activities n.e.c.
Registered Address
primera accountants limited, fir, spitalfields house, borehamwood, WD6 2FX
Website
denpharmltd.comdenpharm ltd Estimated Valuation
Pomanda estimates the enterprise value of DENPHARM LTD at £113k based on a Turnover of £214k and 0.53x industry multiple (adjusted for size and gross margin).
denpharm ltd Estimated Valuation
Pomanda estimates the enterprise value of DENPHARM LTD at £135.6k based on an EBITDA of £43.6k and a 3.11x industry multiple (adjusted for size and gross margin).
denpharm ltd Estimated Valuation
Pomanda estimates the enterprise value of DENPHARM LTD at £344.2k based on Net Assets of £151.8k and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Denpharm Ltd Overview
Denpharm Ltd is a live company located in borehamwood, WD6 2FX with a Companies House number of 11228555. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in February 2018, it's largest shareholder is muntazir mehdi hamza ali with a 50% stake. Denpharm Ltd is a young, micro sized company, Pomanda has estimated its turnover at £214k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Denpharm Ltd Health Check
Pomanda's financial health check has awarded Denpharm Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £214k, make it smaller than the average company (£849.3k)
- Denpharm Ltd
£849.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (8.3%)
- Denpharm Ltd
8.3% - Industry AVG
Production
with a gross margin of 19%, this company has a higher cost of product (39.5%)
- Denpharm Ltd
39.5% - Industry AVG
Profitability
an operating margin of 20.3% make it more profitable than the average company (5.8%)
- Denpharm Ltd
5.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (14)
2 - Denpharm Ltd
14 - Industry AVG
Pay Structure
on an average salary of £29.2k, the company has an equivalent pay structure (£29.2k)
- Denpharm Ltd
£29.2k - Industry AVG
Efficiency
resulting in sales per employee of £107k, this is more efficient (£73.5k)
- Denpharm Ltd
£73.5k - Industry AVG
Debtor Days
it gets paid by customers after 24 days, this is near the average (27 days)
- Denpharm Ltd
27 days - Industry AVG
Creditor Days
its suppliers are paid after 483 days, this is slower than average (36 days)
- Denpharm Ltd
36 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Denpharm Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Denpharm Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 60.2%, this is a higher level of debt than the average (37.2%)
60.2% - Denpharm Ltd
37.2% - Industry AVG
DENPHARM LTD financials
Denpharm Ltd's latest turnover from March 2024 is estimated at £214 thousand and the company has net assets of £151.8 thousand. According to their latest financial statements, Denpharm Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 366,850 | 120,900 | 124,950 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 366,850 | 120,900 | 124,950 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 14,424 | 169,801 | 204,629 | 78,013 | 30,412 | 47,980 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 14,424 | 169,801 | 204,629 | 78,013 | 30,412 | 47,980 |
| total assets | 381,274 | 290,701 | 329,579 | 78,013 | 30,412 | 47,980 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 229,493 | 171,588 | 261,455 | 20,003 | 18,523 | 41,332 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 229,493 | 171,588 | 261,455 | 20,003 | 18,523 | 41,332 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 229,493 | 171,588 | 261,455 | 20,003 | 18,523 | 41,332 |
| net assets | 151,781 | 119,113 | 68,124 | 58,010 | 11,889 | 6,648 |
| total shareholders funds | 151,781 | 119,113 | 68,124 | 58,010 | 11,889 | 6,648 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Feb 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 0 | 0 | 0 | |||
| Amortisation | 0 | 0 | 0 | |||
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -155,377 | -34,828 | 126,616 | 47,601 | -17,568 | 47,980 |
| Creditors | 57,905 | -89,867 | 241,452 | 1,480 | -22,809 | 41,332 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
denpharm ltd Credit Report and Business Information
Denpharm Ltd Competitor Analysis
Perform a competitor analysis for denpharm ltd by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in WD6 area or any other competitors across 12 key performance metrics.
denpharm ltd Ownership
DENPHARM LTD group structure
Denpharm Ltd has 1 subsidiary company.
denpharm ltd directors
Denpharm Ltd currently has 2 directors. The longest serving directors include Mr Riaz Ali (Feb 2018) and Dr Muntazir Ali (Dec 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Riaz Ali | England | 58 years | Feb 2018 | - | Director |
| Dr Muntazir Ali | England | 62 years | Dec 2021 | - | Director |
P&L
March 2024turnover
214k
-58%
operating profit
43.6k
0%
gross margin
19%
-1.89%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
151.8k
+0.27%
total assets
381.3k
+0.31%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
denpharm ltd company details
company number
11228555
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
February 2018
age
7
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
primera accountants limited, fir, spitalfields house, borehamwood, WD6 2FX
Bank
-
Legal Advisor
-
denpharm ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to denpharm ltd.
denpharm ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DENPHARM LTD. This can take several minutes, an email will notify you when this has completed.
denpharm ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
